|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Medical Game-Changers Beckonabout 9 years ago
Investing in Africa: How to Do It Rightabout 9 years ago
The Winning Edge in Emerging Marketsabout 9 years ago
Paula Apsell: A Storied Life in Scienceabout 9 years ago
Going to the Edgeabout 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaabout 9 years ago
Executive Pay and Innovationabout 9 years ago
Science: The Communal Languageabout 9 years ago
Will NICE ‘Go Commercial’?about 9 years ago
Country Report: MexicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma
3
Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits
4
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
5